Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The myelin oligodendrocyte glycoprotein directly binds nerve growth factor to modulate central axon circuitry.
Efficacy of fingolimod is superior to injectable disease modifying therapies in second-line therapy of relapsing remitting multiple sclerosis.
Oral and craniofacial manifestations of multiple sclerosis: implications for the oral health care provider.
Association between DPP6 polymorphism and the risk of progressive multiple sclerosis in Northern and Southern Europeans.
Central nervous system demyelinating diseases and recombinant hepatitis B vaccination: a critical systematic review of scientific production.
Axonal loss in non-optic neuritis eyes of patients with multiple sclerosis linked to delayed visual evoked potential.
Cell therapy for multiple sclerosis: an evolving concept with implications for other neurodegenerative diseases.
Multiple sclerosis and herpesvirus interaction.
Multiple Sclerosis: A Disease of Affluence?.
Neuroplasticity and functional recovery in multiple sclerosis.
Comparative study on the therapeutic potential of neurally differentiated stem cells in a mouse model of multiple sclerosis.
Energy conservation for fatigue management in multiple sclerosis: a pilot randomized controlled trial.
Identifying and treating pain caused by MS.
Glia in mammalian development and disease.
Quantification of gait kinematics and walking ability of people with multiple sclerosis who are new users of functional electrical stimulation.
New TYSABRI® analysis at AAN annual meeting shows improved walking speed in significant number of MS patients
Progression of multiple sclerosis is associated with gender differences in glutathione S-transferase P1 detoxification pathway.
Complications of Immunosuppressive/Immunomodulatory Therapy in Neurological Diseases.
Adolescents' experiences on coping with parental multiple sclerosis: a grounded theory study.
Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis.
Protection of tregs, suppression of Th1 and th17 cells, and amelioration of experimental allergic encephalomyelitis by a physically-modified saline.
Critical role for PDE4 subfamilies in the development of experimental autoimmune encephalomyelitis.
HLA-DRB1 does not have a role in clinical response to interferon-beta among Iranian multiple sclerosis patients.
Cannabis for spasticity and multiple sclerosis
A rare presentation of atypical demyelination: tumefactive multiple sclerosis causing Gerstmann's syndrome.

Pages